On the Mechanism Determining the Th1/Th2 Phenotype of an Immune Response, and its Pertinence to Strategies for the Prevention, and Treatment, of Certain Infectious Diseases

Scandinavian Journal of Immunology

Volumn 79, Issue 6, 2014, Pages 361-376

  Bretscher, P A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN;

ANTIBODY RESPONSE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; INFECTION PREVENTION; MYCOBACTERIUM TUBERCULOSIS; NOTE; PHENOTYPE; PRIORITY JOURNAL; TH1 TH2 BALANCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; ERYTHROCYTES; HUMANS; INTERLEUKIN-4; MEMBRANE PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; TH1 CELLS; TH2 CELLS; TUBERCULOSIS; UBIQUITIN-PROTEIN LIGASES;

EID: 84901194899     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12175     Document Type: Note

References (69)

1. Clerici C, Shearer GM. A TH1→ TH2 switch is a critical step in the etiology of AIDS. Immunol Today 1993;14:107-11.
2. Turk JL, Bryceson ADM. Immunological phenomena in leprosy and related diseases. Adv Immunol 1971;13:209-66.
3. Mosmann TR, Cherwinski H, Bond HW, Giedlin MA, Coffman RL. Two types of murine helper T cell clones. I Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:7348-57.
4. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional prop[erties. Ann Rev Immunol 1989;7:145-73.
5. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon-gamma or IL-4 during resolution or progression of murine lieshmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989;169:59-72.
6. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 1992;257:539-42.
7. Hailu A, Menon JN, Berhe N, Gedamu L, Hassard TH, Bretscher PA. Distinct immunity in visceral leishmaniasis patients from that in subclinically infected and drug-cured people: implications for the mechanism underlying drug cure. J Infect Dis 2001;184:112-5.
8. Ivanov I, Atarashi K, Manel N et al. Induction of Th17 cells by segmented, filamentous bacteria. Cell 2010;139:485-98.
9. Sun S, Hall JA, Blank RB et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells by retinoic acid. J Exp Med 2007;204:1775-85.
10. Asherson GL, Stone SH. Selective and specific inhibition of 24 hr skin reactions in the guinea pig I. Immune Deviation: description of the phenomenon and the effect of splenectomy. Immunol 1965;9:205-17.
11. Parish CR. The relationship between humoral and cell-mediated immunity. Trans Rev 1972;13:35-66.
12. Bretscher PA. Hypothesis: on the control between cell-mediated IgM and IgG immunity. Cell Immunol 1974;13:171-95.
13. Ramshaw IA, Bretscher PA, Parish CR. Regulation of the immune response. I Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity. Eur J Immunol 1976;6:674-9.
14. Ramshaw IA, Bretscher PA, Mckenzie IFC, Parish CR. Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-Ia sera. Cell Immunol 1977;31:364-9.
15. Ramshaw IA, Bretscher PA, Parish CR. Regulation of the immune response. II Repressor T cells in cyclophosphamide-induced tolerant mice. Eur J Immunol 1977;7:180-5.
16. Moller G. Do suppressor T cells exist? Scand J Immunol 1988;27:247-50.
17. Green DR, Webb DR. Saying the 'S' word in public. Immunol Today 1993;14:523-5.
18. Tuttosi S, Bretscher PA. Antigen-specific CD8 T cells switch the immune response induced by antigen from an IgG to a cell-mediated mode. J Immunol 1992;148:397-403.
19. Salvin SB. Occurrence of DTH during the development of Arthus type sensitivity. J Exp Med 1958;107:109-24.
20. Bretscher PA, Ismail N, Menon JN, Power CA, Uzonna J, Wei G. Vaccination against and treatment of tuberculosis, the leishmaniases and AIDS: perspective from basic immunology and immunity to chronic intracellular infections. Cell Mol Life Sci 2001;58:1879-96.
21. Lagrange PH, Mackaness GB, Miller TE. Influence of dose and route of antigen injection on the immunological induction of T cells. J Exp Med 1974;139:528-42.
22. Menon JN, Bretscher PA. Parasite dose determines the Th1/Th2 nature of the immune response to Leishmania major independently of infection route and strain of host or parasite. Eur J Immunol 1998;28:4020-8.
23. Power CA, Wei G, Bretscher PA. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunizationis by the intravenous, subcuateneous or intradermal route. Inf Immun 1988;66:5743-70.
24. Kiros T, Power C, Wei G, Bretscher PA. Immunization of newborn and adult mice with low numbers of BCG leads to Th1 responses, Th1 imprints and enhanced protection upon BCG challenge. Immunotherapy 2010;2:25-35.
25. Buddle F, de Lisle GW, Pfeffer A, Aldwell FE. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 1995;13:1123-30.
26. Mitchison NA. Immunological paralysis as a dosage phenomenon. In: Cinader B, ed. Regulation of the Antibody Response, Springfield, Ill: CC Thomas, 1967:54-67.
27. Pearson MN, Raffel S. Macrophage-digested antigen as inducer of delayed hypersensitivity. J Exp Med 1971;133:494-505.
28. Bretscher PA. The activation and inactivatio of mature CD4 T cells: a case for peripheral self-nonself discrimination. Scand J Immunol, in press.
29. Humphrey JH, Dourmashkin RR. The lesions in cell membranes caused by complement. Adv Immunol 1969;11:75-117.
30. Klein G. Tumor-specific transplantation antigens: G.H.A Clowes Memorial Lecture. Can Res 1968;28:625-35.
31. Lesley J, Hyman R, Dennert G. The effect of antigen density on complement-mediated lysis. T cell-mediated killing and antigenic modulation. J Nat Can Inst 1974;53:1759-65.
32. Wiedermann G, Denk M, Stemberger H, Eckerstorfer E, Tappenheimer G. Influence of the antigenicity of target cells on the antibody-mediated cytotoxicity of non-sensitiused lymphocytes. Cell Imunol 1975;17:440-6.
33. Wicker LS, Miller BJ, Muller Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 1986;35:855-60.
34. Shahinian A, Pfeffer K, Lee KP et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science, 1993;261:609-12.
35. Lenschow L, Herold KC, Rhee L et al. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 1996;5:285-93.
36. Ismail N, Bretscher PA. More antigen-dependent CD+ Tcell/CD4+ T cell interactions are required for the primary generation of Th2 than of Th1 cells. Eur J Immunol 2001;31:1765-71.
37. Ismail N, Basten A, Briscoe H, Bretscher PA. Increasing the foreignness of an antigen, by coupling a second and foreign antigen to it, increases the Th2 component of the immune response to the first antigen. Immunol 2004;115:34-41.
38. Bretscher PA. In vitro analysis of the cellular interactions between unprimed lymphocytes responsible for determining the class of response an antigen induces: specific T cells switch a cell-mediated response to a humoral response. J Immunol 1983;131:1103-7.
39. Constant S, Pfeiffer C, Woodward A, Pasqualini T, Bottomly K. Extent of T cell receptor ligation can determine the functional differentiation of naïve CD4 T cells. J Exp Med 1995;182:1591-6.
40. Power CA, Grand GL, Ismail N, Peters NC, Yurkowski DP, Bretscher PA. A valid ELISPOT assay for enumration o0f ex-vivo, antigen-specific, IFNγ-producing cells. J Immunmol Methods 1999;227:99-107.
41. Rudulier CD, Kroeger DR, Bretscher PA. The activation, by antigen, of naïve TCR transgenic CD4 T cells cultured at physiological, rather than artificially high, frequencies accurately reflects in-vivo activation of normal numbers of naïve CD4 T cells. Cell Immunol 2012;274:115-20.
42. Rudulier CR, McKinstry K, Al-Yassin G, Kroeger DR, Bretscher PA. The number of responding CD4 T cells and the dose of antigen conjointly determine the Th1/Th2 phenotype via CD28/B7 interactions. J Immunol 2014; in press.
43. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of TH1 CD4 T cells though IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-9.
44. Corthay A. A three-cell model for activation of naïve T helper cells. Scand J Immunol 2006;6:93-6.
45. Abdi K, Singh N, Matzinger P. T-cell control of IL-12p75 production. Scand J Immunol 2006;64:83-92.
46. Swain SL, Weinberg AD, English M, Huston GH. IL-4 directs the development of Th2-like helper effectors. J of Immunol 1990;145:3796-806.
47. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Lockseley RM. Cure of murine leishmanisis with anti-IL4 monoclonal antibody. J Exp Med 1999;171:115-27.
48. Miyamoto M, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001;413:531-4.
49. Sokol CL, Chu N, Yu S, Nish SA, Laufer TM, Medzhitov R. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol 2009;10:713-20.
50. Fearon DT, Locksley RM. The instructive role if innate immunity in the acquired immune response. Science 1996;272:50-4.
51. Titus RG, Ceredig R, Cerottini JC, Louis JA. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmanisis in genetically susceptible BALB/c mice. J Immunol 1985;135:2108-14.
52. Rus V, Svetic A, Nguyen P, Gause WC, Via CS. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft versus host disease. Regulatory role of donor CD8 + T cells. J Immunol, 1995;155:2396-406.
53. Ismail N, Bretscher PA. The Th1/Th2 nature of concurrent immune responses to unrelated antigens can be independent. J Immunol 1999;163:4842-50.
54. Jutel M, Akdis M, Budak F et al. IL-10 and TGF-b cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003;33:1205-14.
55. Karlsson MR, Rugtveit J, Brandtzaeg T. Allergen-responsive CD4 + CD25 regulatory T cells in children who have out-grown cow's milk allergy. J Exp Med 2004;199:1679-88.
56. 4 antibody by dynamic Fab arm exchange. Science 2007;317:1554-7.
57. Langford TD, Housely MP, Boes M et al. Central importance of immunoglobulin. A in host defense against Giardia spp. J Immunol 2002;70:11-8.
58. 4-restricted response. J Immunol 1983;130:722-6.
59. Sakaguichi S, Takahashi T, Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. I Requirement for Lyt-1 effectoer cells for oocytes damage after adoptive transfer. J Exp Med 1982;156:1565-86.
60. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;299:1259-60.
61. Meiler J, Zumkehr J, Klunker S, Ruckert B, Akdis CA, Akdis M. In vivo switch to IL-10-producing T regulatory cells in high dose allergen exposure. J Exp Med 2008;205:2887-98.
62. Salk J, Bretscher PA, Salk PL, Clerici M, Shearer GM. A strategy for prophylatic vaccination against HIV. Science 1993;260:1269-72.
63. Bretscher PA, Menon JN, Power C, Uzonna JE, Wei G. A case for neonatal, low dose BCG vaccination. Scand J Infect Dis 2001;33:253-7.
64. Hamilton D, Bretscher PA. The commonality in the regulation of the immune response to most tumors: the prevalence of immune class deviation as a tumor escape mechanism and its significance for vaccination and immunotherapy. Cancer Ther 2008;6:745-54.
65. Hamilton DH, Ismail N, Kroeger DR, Rudulier CD, Bretscher PA. Macroimmunology and immunotherapy of cancer. Immunotherapy 2009;1:367-83.
66. North RJ. Down regulation of the antitumor response. Adv Cancer Res 1985;45:1-78.
67. Hamilton DH, Bretscher PA. Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer. Cancer Immunol Immunother 2008;57:1125-36.
68. Uzonna JE, Bretscher PA. Anti-IL4 antibody therapy causes regressionof chronic lesions caused by medium-dose Leishmania major infection. Eur J Immunol 2001;31:3175-84.
69. 2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression. AIDS Res Hum Retroviruses 2001;17:1435-46.